CN107596063A - A kind of Chinese medicine composition for treating renal anemia - Google Patents

A kind of Chinese medicine composition for treating renal anemia Download PDF

Info

Publication number
CN107596063A
CN107596063A CN201711015470.5A CN201711015470A CN107596063A CN 107596063 A CN107596063 A CN 107596063A CN 201711015470 A CN201711015470 A CN 201711015470A CN 107596063 A CN107596063 A CN 107596063A
Authority
CN
China
Prior art keywords
parts
radix
treatment
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711015470.5A
Other languages
Chinese (zh)
Inventor
王炎强
李香玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Weifang Medical University
Original Assignee
Weifang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weifang Medical University filed Critical Weifang Medical University
Priority to CN201711015470.5A priority Critical patent/CN107596063A/en
Publication of CN107596063A publication Critical patent/CN107596063A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine composition for treating renal anemia, and 10 30 parts of Chinese yam, 10 30 parts of matrimony vine is made by the medicine of following parts by weight, 10 30 parts of the bark of eucommia, 10 20 parts of radix cyathulae, 10 30 parts of Radix Codonopsis, 10 30 parts of eclipta, 5 20 parts of Radix Angelicae Sinensis, 5 20 parts of peach kernel, 5 20 parts of safflower, 5 20 parts of Ligusticum wallichii, 10 30 parts of cultivated land, 10 40 parts of the fleece-flower root, 10 30 parts of motherwort, 5 20 parts of radix glycyrrhizae, according to certain compatibility requirement, by being processed into.

Description

A kind of Chinese medicine composition for treating renal anemia
Technical field
The invention belongs to technical field of traditional Chinese medicines, more particularly, to a kind of Chinese medicine composition for treating renal anemia.
Background technology
CKD (Chronic kidney disease, CKD) is common clinical, frequently-occurring disease, at present into For global public health problem.China's adult large sample investigation in 2012 shows that CKD illness rates are about 10.8%, National CKD patient is about 1.195 hundred million, and white elephant is caused to patient individual, family and society.Renal anemia(Renal Anemia, RA)It is one of most common complication of CKD, and influences the important risk factor of CKD patient's prognosis, haemodialysis It is more common in (Hemodialysis, HD) patient.RA is to cause CKD progress, cardiovascular complication, the weight for increasing the death rate Hazards are wanted, most CKD patient's early stages may occur in which anaemia, as decreased renal function anaemia incidence constantly raises.RA's Diagnosis and treatment are the hot issues of current vast medical matters researcher concern.RA correction is to evaluate the weight of its life span and life quality Index is wanted, and the compliance rate of the treatment rate of current China CKD anemias and hemoglobin (Hemoglobin, Hb) is still very It is low, the diagnosis and treatment of CKD anemias how are improved, increase Hb compliance rate, are still RA treatment facing challenges.Although have proven to Hematopoietin(Erythropoietin, EPO)And the like replacement therapy, it is curative for effect, but because by its payment for medical care Influenceed with, factors such as dosage individual difference, hypoergia;And hypertension, epilepsy, embolism, iatrogenic PRCA be present Deng adverse reaction, it is difficult to obtain good risk/benefit.In a word, the current treatment of doctor trained in Western medicine has significant limitation.
The content of the invention
It is an object of the invention to provide a kind of curative for effect, few side effects, reduce endotoxin level, improve nutritional status, Kidney is protected, shortens Hb reaching standard times, improves clinical symptoms, life quality is improved, delays in the treatment of disease progression-severe kidney The Chinese medicine composition of property anaemia.
The object of the present invention is achieved like this, according to traditional Chinese medical theory, using the unique property of medicine of Chinese medicine,
A kind of Chinese medicine composition for treating renal anemia, Chinese yam 10-30 parts, matrimony vine 10-30 are made by the medicine of following parts by weight Part, bark of eucommia 10-30 parts, radix cyathulae 10-20 parts, Radix Codonopsis 10-30 parts, eclipta 10-30 parts, Radix Angelicae Sinensis 5-20 parts, peach kernel 5-20 parts, Safflower 5-20 parts, Ligusticum wallichii 5-20 parts, cultivated land 10-30 parts, fleece-flower root 10-40 parts, motherwort 10-30 parts, radix glycyrrhizae 5-20 parts, according to Certain compatibility requirement, by being processed into.
Chinese medicine composition of the present invention is prepared to be made up of following raw material medicaments:
Chinese yam 10-30 parts, matrimony vine 10-30 parts, bark of eucommia 10-30 parts, radix cyathulae 10-20 parts, Radix Codonopsis 10-30 parts, eclipta 10- 30 parts, Radix Angelicae Sinensis 5-20 parts, peach kernel 5-20 parts, safflower 5-20 parts, Ligusticum wallichii 5-20 parts, cultivated land 10-30 parts, fleece-flower root 10-30 parts, benefit Brittle Falsepimpernel Herb 10-30 parts, radix glycyrrhizae 5-20 parts
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is:20 parts of Chinese yam, 15 parts of matrimony vine, 15 parts of the bark of eucommia, radix cyathulae 15 Part, 15 parts of Radix Codonopsis, 15 parts of eclipta, 10 parts of Radix Angelicae Sinensis, 12 parts of peach kernel, 10 parts of safflower, 12 parts of Ligusticum wallichii, 15 parts of cultivated land, the fleece-flower root 20 Part, 20 parts of motherwort, 8 parts of radix glycyrrhizae.
The pharmacological action of Chinese medicine of the present invention is as follows:
Chinese yam:It is sweet, flat;Return lung, spleen, kidney channel.Tonifying spleen;Support lung;Reinforce the kidney;Strengthening the essence.For splenasthenic diarrhea, deficiency of food edema, deficiency syndrome of the lung cough Asthma, is quenched one's thirst, and passes out semen, and under band, carbuncle swells, scrofula etc. are controlled in kidney deficiency frequent micturition, external application.
Matrimony vine:It is sweet, flat;Return liver and kidney channel.Nourshing kidney, moistening lung, tonifying liver, improving eyesight.Liver-kidney Yin deficiency is cured mainly, soreness and weakness of waist and knees is dizzy, It is dizzy, the more tears of blurred vision, cough due to consumptive disease, quench one's thirst, seminal emission etc..
The bark of eucommia:It is sweet, warm.Return liver and kidney channel.Nourishing liver and kidney, astringent sperm contracting urine is antiabortive, improving eyesight, antidiarrheal.For impotence and seminal emission, urine There are the heeltap, enuresis frequent micturition, soreness and weakness of waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, fetal irritability, spleen kidney deficiency to rush down;Externally treating leucoderma etc..
Radix cyathulae:Sweet, slight bitter, put down.Return liver and kidney channel.Invigorate blood circulation, dispelling wind and eliminating dampness is easing joint movement, the work(of inducing diuresis for treating strangurtia Effect, cure mainly blood stasis, dysmenorrhoea, difficult labour, placenta retension, joint pain, sufficient impotence muscle contraction, hematuria, blood strangury, injury from falling down etc..
Radix Codonopsis:It is sweet, flat.Returns spleen, lung channel.QI invigorating, promote the production of body fluid, blood-nourishing.For the physically weak burnout of the deficiency of qi in middle-jiao, lung qi virtual loss Cough shortness of breath, the shortness of breath that gas Tianjin two is hindered is thirsty, dizzy palpitaition etc..
Eclipta:It is sweet, sour, tremble with fear.Channel tropism:Return kidney, Liver Channel.Major function:It is nourishing liver and kidney, cooling blood and hemostasis.For tooth pine It is dynamic, poliosis, dizziness and tinnitus, soreness and weakness of waist and knees, YinXuXueRe, haematemesis, bleeding from five sense organs or subcutaneous tissue, hematuria, bloody flux, metrostaxis, traumatism and bleeding Deng.
Radix Angelicae Sinensis:It is sweet, pungent, warm, Return liver, the heart, the spleen channel.Enrich blood, invigorate blood circulation, menstruation regulating, analgesic.For heart-liver blood deficiency, ulcer sores.
Peach kernel:Acrid, bitter, warm.Returns spleen, stomach, liver, lung channel.Promoting qi circulation and relieving pain, lead in tune stagnant.Fullness in chest and hypochondrium is cured mainly, gastral cavity abdomen is swollen Bitterly, vomiting and diarrhea etc..
Safflower:It is pungent, warm.The thoughts of returning home, Liver Channel.Invigorate blood circulation, stasis-dispelling and pain-killing.Cure mainly blood stasis, chest impediment and cardialgia , Disorder lumps in the abdomen product It is poly-, arthralgia etc..
Ligusticum wallichii:It is pungent, warm.Return liver, courage, the heart channel of Hang-Shaoyin.Blood-activating and qi-promoting, wind-expelling pain-stopping.For stagnation of QI and blood, arthralgia pain due to rheumatism.
Cultivated land:Acrid, bitter, warm, returns spleen, stomach, lung channel.During qi-regulating is adjusted, stopping nausea and vomiting by lowering the adverse flow of QI is eliminating dampness and eliminating phlegm.For full vexed, the gastral cavity of chest diaphragm Abdominal distention and pain, do not feel like eating, vomiting etc..
The fleece-flower root:Bitter, sweet, colour temperature.Return liver, kidney channel.Filling liver kidney, benefiting essence-blood, black beard and hair, strengthening the bones and muscles, relax bowel, blood-nourishing Calm the nerves, brain swoon tinnitus, poliosis, soreness and weakness of waist and knees, extremity numbness, neurasthenia, hyperlipemia.
Motherwort:It is arduous, cool in nature.Invigorate blood circulation, silt of dispelling, menstruation regulating, disappear water the effect of.Menoxenia is treated, threatened abortion is had difficult labour, Placenta retension, postpartum anemic fainting, abdominal pain due to blood stasis, metrorrhagia and metrostaxis, hematuria, rush down blood, carbuncle swells sore.
Radix glycyrrhizae:It is sweet, flat, the thoughts of returning home, lung, spleen, stomach.Invigorating middle warmer and replenishing QI, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, harmonizing drug Property.Severe palpilation, intermittent pulse for deficiency of heart-QI, pathopyretic ulcer, abscess of throat.
Renal anemia is mainly because endogenous EPO hyposecretions and toxin are different to medulla hematopoietic system suppression, erythrocyte metabolism Often, the multifactor correlation such as hematopoiesis insufficient raw material, micro milling.Motherland's medical science is belonged to according to its cause of disease, the interpretation of the cause, onset and process of an illness and clinical manifestation In categories such as the traditional Chinese medical science " consumptive disease, oedema, the deficiency of blood ".Traditional Chinese medicine thinks this empty table actually its interpretation of the cause, onset and process of an illness, and this void is declined with spleen kidney deficiency, qi and blood life Change weary source, kidney essense bone is weary, and essence and blood is unable to alternate, causes deficiency in both Qi and blood;Mark is real to be lost with internal organs void, wet turbid what resistance, mixture of asthenia and sthenia, mutually For cause and effect, vicious circle.Treatment is with kidney and spleen invigorating qi and activate blood circulation, and taking into account is turbid to let out silt, and macroscopic view is dialectical to be treated, and giving consideration to both the incidental and fundamental, is attacked Mend it is simultaneous apply, actual situation is gone forward side by side, and qi and blood is laid equal stress on, Yin Shiyin people and preferably principle.Chinese yam, matrimony vine, bark of eucommia nourishing kidney qi, controlling nocturnal emission with astringent drugs are filled out in side Marrow, the source with nourishing liter blood;Radix Angelicae Sinensis, peach kernel, safflower, rhizome of chuanxiong, cultivated land add the promoting blood circulations such as eclipta, Radix Angelicae Sinensis, radix cyathulae, motherwort to mend Blood dredging collateral, stasis eliminatings life are new, QI invigorating dampness elimination, blood-nourishing rising Yang, strong fortune kidney spleen, solid table benefit are defended, nourish cloudy kidney, inducing diuresis for treating strangurtia;Radix glycyrrhizae and Middle emergency, coordinating the drug actions of a prescription.
From in January, 2015-2016 year January the chronic renal insufficiency that our hospital is in hospital with-patient of anemia 75, male 39, female 36.It is randomly divided into treatment group(38)With control group(37).Two groups of patient ages, sex, the course of disease, The cause of disease, severity of anemia, renal function situation, there was no significant difference (P>0.05), there is comparativity.All patients give renal diet, Blood pressure is controlled, maintains the complex treatment such as Water-Electrolyte acid-base balance, chalybeate, folic acid and vitamin B12.Control group gives rHuEPO (Sansheng pharmacy Co., Ltd., Shenyang city)It is subcutaneously injected, dosage is 80-120 u/ (Kg weeks), point 2 injections, continuous 8 weeks. Treatment group 38 gives traditional Chinese medicine for oral administration on the basis of control group.Chinese medicine composition of the present invention was in clinical observation in 2015 to 2016 In -38 patients of severe renal anemia, clinical report is as follows:
1st, general information
The chronic renal insufficiency that our hospital is in hospital with-patient 39 of anemia, male 21, female 18, the age 18~74 It is year, average(45.68±11.39)Year old, chronic nephritis 12 in its protopathy, diabetic nephropathy 10, hypertensive renal damage 8 Example, IgA nephrosis 5, HSPN 2, chronic pyelonephritis 1, drug-induced renal impairment 1.
2nd, case is selected, exclusion standard:
Inclusion criteria:Chronic renal failure Decompensated stage with anaemia nondialytic treatment patient, by American National in 2002 " guidance of kidney trouble life quality " of kidney trouble foundation(K/DOQI)By stages up to 3-5 phases, GFR<60ml/min/1.73m2, Scr is higher than normal, Hb≤90g/L, Hct≤30%.Exclusion standard:Used rHuEPO and traditional Chinese herbal decoction or treatment nephrosis in January Chinese patent drug person;There is blood transfusion history person in 2 weeks;Exist and acute and chronic lose blood or receive hormone, cell toxicant or other influence red blood cells Drug therapy person(Chalybeate, folic acid and vitamin B12Except);Refractory hypertension person;Severe malnutrition, Water-Electrolyte soda acid Balance disorders person;There are bleeding and obvious hemorrhagic tendency person;In the presence of serious cardiopulmonary insufficiency, Diabetic Acute complication, tumour, Liver patient;There are acute and chronic infection or autoimmune disease person;Fail to complete the course for the treatment of in therapeutic process or serious adverse reaction occur Person etc..
3rd, treatment method
3.1 prescription:Chinese yam 20g, matrimony vine 15g, bark of eucommia 15g, radix cyathulae 15g, Radix Codonopsis 15g, eclipta 15g, Radix Angelicae Sinensis 10g, peach kernel 12g, safflower 10g, rhizome of chuanxiong 12g, cultivated land 15g, fleece-flower root 20g, motherwort 20g, radix glycyrrhizae 8g.Added and subtracted with disease, 15 doses are 1 course for the treatment of.
3.2 preparation method:Routinely decoction is made in technique to said medicine.
3.3 instructions of taking:1 dose every time, one time a day, 15 days are 1 course for the treatment of, even served 3 courses for the treatment of.
4th, treatment results:
4.1 the standard of curative effect evaluation:
It is effective:During treatment or terminate after, Hb risings >=30g/L and(Or)Hct rises >=0.1, or Hb reaches 100g/L or Hct Up to 0.3, Anemia improves;Effectively:After treatment end Hb risings >=15g/L and(Or)Hct rises >=0.05, and Anemia changes It is kind;It is invalid:These parameters are unchanged or deteriorate.4.2 result:Clinical remission 26 (83.9%), effective 5 (16.1%).
4.2 curative effect comparison therapy groups 39, effective 10, effective 24, invalid 5, total effective rate is 87. 2%.
Integration is (11.79 ± 2.15), (6.12 ± 1.39) before and after treatment for 4.3 Chinese medicine syndrome integrals change treatment group, poor It is different have conspicuousness (P<0.01)。
RBC, Hb, Hct, Ret substantially rise after 4.4 hematological indices comparison therapies, and compared with before treatment, difference has aobvious Work property (P<0. 05).
The hematological indices of table 1 compare (x±s)
4. raised after the treatment of 5 iron metabolism Indexes Comparisons before sTfR, SF, TS relatively treatment (P<0.05) ;Difference has conspicuousness (P<0. 05) 。
Iron metabolism Indexes Comparison (the x of table 2±s)
BUN, SCr are decreased obviously after the treatment of 4.6 liver kidney function Indexes Comparison treatment groups, and ALB substantially rises, poor compared with before treatment It is different have conspicuousness (P<0.05)。
The liver kidney function Indexes Comparison (x of table 3±s)
Embodiment
With reference to embodiment, the present invention is further illustrated, and following embodiments are merely to illustrate of the invention and right The present invention does not limit.
Embodiment 1, a kind of Chinese medicine composition for treating renal anemia, it is by Chinese yam 20g, matrimony vine 15g, bark of eucommia 15g, river ox Knee 12g, Radix Codonopsis 15g, eclipta 15g, Radix Angelicae Sinensis 10g, peach kernel 12g, safflower 10g, rhizome of chuanxiong 12g, cultivated land 15g, fleece-flower root 25g, benefit Brittle Falsepimpernel Herb 20g, radix glycyrrhizae 8g are made.
Embodiment 2, a kind of Chinese medicine composition for treating renal anemia, it is by Chinese yam 20g, matrimony vine 15g, bark of eucommia 15g, river ox Knee 15g, Radix Codonopsis 15g, eclipta 12g, Radix Angelicae Sinensis 10g, peach kernel 15g, safflower 15g, rhizome of chuanxiong 15g, cultivated land 15g, fleece-flower root 20g, benefit Brittle Falsepimpernel Herb 20g, radix glycyrrhizae 9g are made.
Embodiment 3, a kind of Chinese medicine composition for treating renal anemia, it is by Chinese yam 30g, matrimony vine 20g, bark of eucommia 15g, river ox Knee 12g, Radix Codonopsis 20g, eclipta 10g, Radix Angelicae Sinensis 10g, peach kernel 15g, safflower 10g, rhizome of chuanxiong 15g, cultivated land 30g, fleece-flower root 27g, benefit Brittle Falsepimpernel Herb 20g, radix glycyrrhizae 7g are made.
From in January, 2015-2016 year January the chronic renal insufficiency that our hospital is in hospital with-patient of anemia 75, male 39, female 36.It is randomly divided into treatment group(38)With control group(37).Two groups of patient ages, sex, the course of disease, The cause of disease, severity of anemia, renal function situation, there was no significant difference (P>0.05), there is comparativity.All patients give renal diet, Blood pressure is controlled, maintains the complex treatment such as Water-Electrolyte acid-base balance, chalybeate, folic acid and vitamin B12.Control group gives rHuEPO (Sansheng pharmacy Co., Ltd., Shenyang city)It is subcutaneously injected, dosage is 80-120 u/ (Kg weeks), point 2 injections, continuous 8 weeks. Treatment group 38 gives traditional Chinese medicine for oral administration on the basis of control group.Chinese medicine composition of the present invention was in clinical observation in 2015 to 2016 In -38 patients of severe renal anemia, clinical report is as follows:
1st, general information
The chronic renal insufficiency that our hospital is in hospital with-patient 39 of anemia, male 21, female 18, the age 18~74 It is year, average(45.68±11.39)Year old, chronic nephritis 12 in its protopathy, diabetic nephropathy 10, hypertensive renal damage 8 Example, IgA nephrosis 5, HSPN 2, chronic pyelonephritis 1, drug-induced renal impairment 1.
2nd, case is selected, exclusion standard:
Inclusion criteria:Chronic renal failure Decompensated stage with anaemia nondialytic treatment patient, by American National in 2002 " guidance of kidney trouble life quality " of kidney trouble foundation(K/DOQI)By stages up to 3-5 phases, GFR<60ml/min/1.73m2, Scr is higher than normal, Hb≤90g/L, Hct≤30%.Exclusion standard:Used rHuEPO and traditional Chinese herbal decoction or treatment nephrosis in January Chinese patent drug person;There is blood transfusion history person in 2 weeks;Exist and acute and chronic lose blood or receive hormone, cell toxicant or other influence red blood cells Drug therapy person(Chalybeate, folic acid and vitamin B12Except);Refractory hypertension person;Severe malnutrition, Water-Electrolyte soda acid Balance disorders person;There are bleeding and obvious hemorrhagic tendency person;In the presence of serious cardiopulmonary insufficiency, Diabetic Acute complication, tumour, Liver patient;There are acute and chronic infection or autoimmune disease person;Fail to complete the course for the treatment of in therapeutic process or serious adverse reaction occur Person etc..
3rd, treatment method
3.1 prescription:Chinese yam 20g, matrimony vine 15g, bark of eucommia 15g, radix cyathulae 15g, Radix Codonopsis 15g, eclipta 15g, Radix Angelicae Sinensis 10g, peach kernel 12g, safflower 10g, rhizome of chuanxiong 12g, cultivated land 15g, fleece-flower root 20g, motherwort 20g, radix glycyrrhizae 8g.Added and subtracted with disease, 15 doses are 1 course for the treatment of.
3.2 preparation method:Routinely decoction is made in technique to said medicine.
3.3 instructions of taking:1 dose every time, one time a day, 15 days are 1 course for the treatment of, even served 3 courses for the treatment of.
4th, treatment results:
4.1 the standard of curative effect evaluation:
It is effective:During treatment or terminate after, Hb risings >=30g/L and(Or)Hct rises >=0.1, or Hb reaches 100g/L or Hct Up to 0.3, Anemia improves;Effectively:After treatment end Hb risings >=15g/L and(Or)Hct rises >=0.05, and Anemia changes It is kind;It is invalid:These parameters are unchanged or deteriorate.4.2 result:Clinical remission 26 (83.9%), effective 5 (16.1%).
4.2 curative effect comparison therapy groups 39, effective 10, effective 24, invalid 5, total effective rate is 87. 2%.
Integration is (11.79 ± 2.15), (6.12 ± 1.39) before and after treatment for 4.3 Chinese medicine syndrome integrals change treatment group, poor It is different have conspicuousness (P<0.01)。
RBC, Hb, Hct, Ret substantially rise after 4.4 hematological indices comparison therapies, and compared with before treatment, difference has aobvious Work property (P<0. 05).
The hematological indices of table 1 compare (x±s)
4. raised after the treatment of 5 iron metabolism Indexes Comparisons before sTfR, SF, TS relatively treatment (P<0.05) ;Difference has conspicuousness (P<0. 05) 。
Iron metabolism Indexes Comparison (the x of table 2±s)
BUN, SCr are decreased obviously after the treatment of 4.6 liver kidney function Indexes Comparison treatment groups, and ALB substantially rises, poor compared with before treatment It is different have conspicuousness (P<0.05)。
The liver kidney function Indexes Comparison (x of table 3±s)

Claims (3)

  1. A kind of 1. Chinese medicine composition for treating renal anemia, it is characterised in that:Chinese yam 10-30 is made by the medicine of following parts by weight Part, matrimony vine 10-30 parts, bark of eucommia 10-30 parts, radix cyathulae 10-20 parts, Radix Codonopsis 10-30 parts, eclipta 10-30 parts, Radix Angelicae Sinensis 5-20 Part, peach kernel 5-20 parts, safflower 5-20 parts, Ligusticum wallichii 5-20 parts, cultivated land 10-30 parts, fleece-flower root 10-40 parts, motherwort 10-30 parts, Radix glycyrrhizae 5-20 parts.
  2. A kind of 2. Chinese medicine composition for treating renal anemia as claimed in claim 1, it is characterised in that:Chinese yam 10-30 parts, matrimony vine 10-30 parts, bark of eucommia 10-30 parts, radix cyathulae 10-20 parts, Radix Codonopsis 10-30 parts, eclipta 10-30 parts, Radix Angelicae Sinensis 5-20 parts, peach kernel 5-20 parts, safflower 5-20 parts, Ligusticum wallichii 5-20 parts, cultivated land 10-30 parts, fleece-flower root 10-30 parts, motherwort 10-30 parts, radix glycyrrhizae 5-20 Part.
  3. A kind of 3. Chinese medicine composition for treating renal anemia as claimed in claim 1, it is characterised in that:20 parts of Chinese yam, matrimony vine 15 Part, 15 parts of the bark of eucommia, 15 parts of radix cyathulae, 15 parts of Radix Codonopsis, 15 parts of eclipta, 10 parts of Radix Angelicae Sinensis, 12 parts of peach kernel, 10 parts of safflower, Ligusticum wallichii 12 Part, 15 parts of cultivated land, 20 parts of the fleece-flower root, 20 parts of motherwort, 8 parts of radix glycyrrhizae.
CN201711015470.5A 2017-10-26 2017-10-26 A kind of Chinese medicine composition for treating renal anemia Pending CN107596063A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711015470.5A CN107596063A (en) 2017-10-26 2017-10-26 A kind of Chinese medicine composition for treating renal anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711015470.5A CN107596063A (en) 2017-10-26 2017-10-26 A kind of Chinese medicine composition for treating renal anemia

Publications (1)

Publication Number Publication Date
CN107596063A true CN107596063A (en) 2018-01-19

Family

ID=61080049

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711015470.5A Pending CN107596063A (en) 2017-10-26 2017-10-26 A kind of Chinese medicine composition for treating renal anemia

Country Status (1)

Country Link
CN (1) CN107596063A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029550A1 (en) * 2004-09-16 2006-03-23 Xinting Wang Hemostatic mistura of ipomoea balatas leaves, methods of preparation and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029550A1 (en) * 2004-09-16 2006-03-23 Xinting Wang Hemostatic mistura of ipomoea balatas leaves, methods of preparation and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
鲍景龙等: "益气养血补肾药为主治疗肾性贫血的临床观察", 《北京中医》 *

Similar Documents

Publication Publication Date Title
CN104383132B (en) Traditional Chinese medicine preparation used for treating gastric ulcer and preparation method
CN106266463A (en) A kind of Chinese medicine composition for treating hyperuricemia and application thereof
CN106728863A (en) It is a kind of to treat Chinese medicine of diabetes and preparation method thereof
CN103800800A (en) Medicine for nursing acute respiratory distress syndrome (ARDS) and preparation method thereof
CN101850080B (en) Chinese medicinal composition for relieving hormone side effect
CN102641377B (en) Medicament for treating femoral head necrosis
CN104825736A (en) Traditional Chinese medicine for treating hepatitis B
CN107596063A (en) A kind of Chinese medicine composition for treating renal anemia
CN103251889A (en) Traditional Chinese medicine composition for treating agalactia
CN103169882A (en) Traditional Chinese medicine composition for treating diabetes
CN103520407B (en) Chinese medicinal preparation for treating renal dialysis complications and preparation method thereof
CN103585414B (en) Pharmaceutical composition for treating sciatica and osteoporosis
CN105902872A (en) Traditional Chinese medicine composition for treating edema
CN105311210A (en) Pharmaceutical composition for treating rheumatoid bone diseases
CN105250809A (en) Traditional Chinese medicine composition for treating dermatomyositis
CN104645163A (en) Traditional Chinese medicine composition for treating psoriasis
CN104324314A (en) Pharmaceutical composition for treating gastropathy
CN104225074A (en) Traditional Chinese medicinal pill for treating diabetes
CN102423367B (en) Beautifying and blood-activating medicament
CN114917310B (en) Traditional Chinese medicine for treating 3-5 stages of chronic kidney disease and preparation method thereof
CN114272344B (en) Traditional Chinese medicine composition for treating qi-yin deficiency and blood stasis type viscera dysfunction, preparation and application
CN103432422B (en) Traditional Chinese medicine for treating chronic gastritis
CN106139116A (en) A kind of Chinese medicine composition preventing and treating fat type Ⅱdiabetes mellitus merging dyslipidemia
CN106266838A (en) A kind of for Chinese medicine composition treating stranguria and preparation method thereof
CN100482259C (en) Chinese medicine for treating cervical spondylosis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180119

RJ01 Rejection of invention patent application after publication